Scholarly Index
Ricardo J. Samms
Eli Lilly (United States); 2,097 total citations; 45 total publications; best world rank #101
Eli Lilly (United States)
2,097Total citations
45Total publications
22H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Fibroblast Growth Factor Research | Lifetime | 889 | US 361 | 90.52 |
| Regulation of Appetite and Obesity | 2021-2025 | 101 | US 32 | 91.88 |
| Neuropeptides and Animal Physiology | 2021-2025 | 149 | US 49 | 89.69 |
| Diabetes Treatment and Management | 2021-2025 | 876 | US 281 | 91.31 |